Fulgent Genetics (FLGT) CEO receives stock awards and tax share withholding
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Fulgent Genetics, Inc. director and CEO Ming Hsieh reported multiple equity-related transactions in the company’s common stock. On February 24, 2026, he acquired shares at a price of $0.00 per share through grants and vesting of restricted stock units tied to performance milestones and service-based conditions.
On the same date, shares were also disposed of at $23.09 per share, and on February 23, 2026 at $23.01 per share, to satisfy tax withholding obligations triggered by those vestings, rather than open‑market sales. The filing also shows significant indirect holdings through the Dynasty Trust, The Ming Hsieh Trust, a Uniform Transfers to Minors Act account, and an immediate family member’s account, with varying levels of voting and dispositive power as described in the footnotes.
Positive
- None.
Negative
- None.
Insider Trade Summary
12 transactions reported
Mixed
12 txns
Insider
Hsieh Ming
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 19,067 | $0.00 | -- |
| Grant/Award | Common Stock | 39,802 | $0.00 | -- |
| Grant/Award | Common Stock | 59,276 | $0.00 | -- |
| Tax Withholding | Common Stock | 10,230 | $23.09 | $236K |
| Tax Withholding | Common Stock | 21,354 | $23.09 | $493K |
| Tax Withholding | Common Stock | 31,760 | $23.09 | $733K |
| Grant/Award | Common Stock | 69,294 | $0.00 | -- |
| Tax Withholding | Common Stock | 2,167 | $23.01 | $50K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 816,121 shares (Direct);
Common Stock — 7,895,115 shares (Indirect, By Trust)
Footnotes (1)
- The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023. Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 23, 2023. Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 26, 2024. Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 25, 2025. The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 23, 2023. The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 26, 2024. The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 25, 2025. Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after March 1, 2026, and 1/12th of such shares vesting at the end of every three-month period thereafter over the remaining 24 months, subject to continued service for Issuer on each vesting date. Securities held by the Dynasty Trust. Mr. Hsieh is the grantor of the Dynasty Trust and he and his spouse, Eva Hsieh, and Jian Xie serve on the investment committee of the Dynasty Trust. Mr. Hsieh disclaims any beneficial interest except with respect to any pecuniary interest therein. Securities held by The Ming Hsieh Trust (the "Hsieh Trust"). Mr. Hsieh is the trustee of the Hsieh Trust and possesses the sole voting and dispositive power with respect to securities held by the Hsieh Trust. Shares held in a Uniform Transfers to Minor Act account for which Ming Hsieh acts as custodian and possesses the sole voting and dispositive power. Shares, which were previously held in a Uniform Transfers to Minor Act account, now held by an immediate family member residing in the same household as Ming Hsieh.
FAQ
What insider transactions did FLGT CEO Ming Hsieh report?
Ming Hsieh reported equity grants and restricted stock unit vesting in Fulgent Genetics common stock, plus related tax-withholding share dispositions. These transactions reflect compensation and tax settlements, not open-market buying or selling activity, and update his direct and indirect ownership positions.
What types of stock awards did FLGT grant to Ming Hsieh?
Ming Hsieh’s transactions include performance-based restricted stock units that vested upon meeting milestones and restricted stock units that vest over three years starting after March 1, 2026. These awards are part of his long-term equity compensation in Fulgent Genetics.
How do trusts affect Ming Hsieh’s ownership in Fulgent Genetics (FLGT)?
The filing notes securities held by a Dynasty Trust, The Ming Hsieh Trust, a Uniform Transfers to Minors Act account, and an immediate family member. Hsieh has varying voting and dispositive powers; he also disclaims beneficial interest in some trust-held shares except for pecuniary interests.
Do the reported FLGT transactions change Ming Hsieh’s role or control at the company?
The transactions update equity ownership through grants, vesting, and tax withholding but do not indicate any change in Ming Hsieh’s roles as director, Chief Executive Officer, or significant owner at Fulgent Genetics based on the information disclosed in this Form 4.